Lowering the levels of two proteins involved in nerve cell development and tightly linked to the activity of UBE3A —…
Alice Melão
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Alice Melão
Manipulation of the mechanism that controls UBE3A gene activation status in the brain may represent an alternative strategy to treat…
A clinical study has began to enroll patients with Angelman syndrome to explore the safety and tolerability of a nutritional…
Evaluating mice bearing Ube3a mutations with a set of five behavioral tests may be a useful tool for preclinical therapy testing…
Anesthesia, Intubation Should Be Considered Before Surgery in Angelman Patients, Case Report Says
Unpredictable responses to anesthesia drugs and difficulty to intubate should be taken into consideration before Angelman syndrome patients undergo…
A new mutation in the UBE3A gene, which was linked to a more mild form of Angelman syndrome,…
Over the past 40 years, a clear majority — 55 to 73 percent — of students with intellectual disabilities spend…
A new technique based on video-recorded behavior analysis can help assess communication ability in children with Angelman syndrome and…
A case of two sisters with classic symptoms of Angelman syndrome but no identifiable genetic mutation highlights the importance…
A possible reason for the reduced ocular pigmentation — the pale eyes — found in people with Angelman syndrome and Prader-Willi syndrome…